Publications

Perry CS. TRRP Rule – The basics part 2: Human health PCLs and look-up tables. TNRCC Environmental Trade Fair presentation and paper, 2002.

Hofelt CS, Honeycutt M, McCoy JT, Haws LC. 2001. Development of a metabolism factor for polycyclic aromatic hydrocarbons for use in multipathway risk assessments for hazardous waste combustion facilities. Reg Toxicol Pharmacol 33(1):60-65; doi: 10.1006/rtph.2000.1438.

Gentry PR, Covington TR, Andersen ME, Clewell HJ. 2002. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol 36:51–68.

Grasty RC, Grey BE, Thibodeaux J, Lau C, Rogers JM. Critical period for increased neonatal mortality induced by perfluorooctane sulfonate (PFOS) in the rat. Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.

Strobel HW, Thompson CM, Antonovic L. 2001. Cytochromes P450 in brain: Function and significance. Curr Drug Metabol 2(2):199–214; doi: 10.2174/1389200013338577.

Booth RG, Moniri NH, Bakker RA, Choksi NY, Nix WB, Timmerman H, Leurs R. 2002. A novel phenylaminotetralin radioligand reveals a sub-population of histamine H1 receptors. J Pharmacol Exper Therapeut 302(1):328–336; doi: 10.1124/jpet.302.1.328.

Staskal DF, DeVito MJ, Ross DG, Birnbaum LS. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.

Love AH, Hunt JR, Roberts ML, Southon JR, Chiarappa-Zucca ML, Dingley KH. 2002. Use of tritium accelerator mass spectrometry for tree ring analysis. Environ Sci Technol 36(13):2848–2852; doi: 10.1021/es015837o. PMID: 12144257.

Williams KE, Carver TA, Miranda JJ, Kautiainen A, Vogel JS, Dingley K, et al. 2002. Attomole detection of in vivo protein targets of benzene in mice: Evidence for a highly reactive metabolite. Mol Cell Proteomics 1(11):885–895; doi: 10.1074/mcp.m200067-mcp200. PMID: 12488464.

Nordyke RJ. 2002. Determinants of PHC productivity and resource utilization: A comparison of public and private physicians in Macedonia. Health Pol 60(1):67-96; doi: 10.1016/s0168-8510(01)00192-0. PMID: 11879946.

Lea IA, Widgren EE, O’Rand MG. 2002. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception. Vaccine 20(11–12):1515–1523; doi: 10.1016/S0264-410X(01)00514-X.

Tao L, Wadsworth S, Mercer J, Mueller C, Lynn K, Siekierka J, August A. 2002. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T- cells. Biochem J 363(Pt 1):175–182; doi: 10.1042/0264-6021:3630175. PMID: 11903060.

Gentry R, Teeguarden J, Sarangapani R, Covington T, Lawrence G, McDonald T, Shipp A, Clewell H. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences in tissue dosimetry. Poster presented at Society of Toxicology 41st Annual Meeting, Nashville, TN, March 2002.

Nordyke RJ, Peabody JW. 2002. Market reforms and public incentives: Finding a balance in the Republic of Macedonia. Soc Sci Med 54(6):939-53; doi: 10.1016/s0277-9536(01)00067-3. PMID: 11996027.

Morrissey RE, Horvath C, Snyder EA, Patrick J, Collins N, Evans E, MacDonald JS. 2002. Porcine toxicology studies of SCH 58500, an adenoviral vector for the p53 gene. Toxicol Sci 65(2):256–265; doi: 10.1093/toxsci/65.2.256. PMID: 11812930.

Covington TR, Teeguarden J, Sarangapani R, Gentry PR, Clewell HJ. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Presentation at the Annual Society for Risk Analysis Conference, Seattle, WA, December 2001.

Haws, L. Risk assessment coordination between EPA and states panelist. Presented at the USEPA Regional Risk Assessors Annual Conference. Bandera, TX, May 2001.

Haws L. Texas risk reduction program rule-Practical applications. Question and Answer Forum Panelist. Presented at the Texas Natural Resource Conservation Commission Environmental Trade Fair, Waste Remediation Track, Austin, TX, April 2001.

Clewell HJ, Gentry PR, Gearhart JM, Covington TR, Banton MI, Andersen ME. 2001. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci 63(2):160–172; doi: 10.1093/toxsci/63.2.160.

Tachovsky JA, McCoy JT, Haws LC. Development and implementation of probabilistic risk assessment protocol in Texas. Presented at the 94th AWMA Conference, Orlando, FL, June 2001.